215168-73-3

Basic information

• Product Name: (R)-N-(tert-butoxycarbonyl)-2-[3-[1-hydroxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]ethylamine
• Synonyms: (R)-N-(tert-butoxycarbonyl)-2-[3-[1-hydroxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]ethylamine
• CAS NO: 215168-73-3
• Molecular Weight: 431.529
• Mol File: 215168-73-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (R)-N-(tert-butoxycarbonyl)-2-[3-[1-hydroxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]ethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-N-(tert-butoxycarbonyl)-2-[3-[1-hydroxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]ethylamine(215168-73-3)
• EPA Substance Registry System: (R)-N-(tert-butoxycarbonyl)-2-[3-[1-hydroxy-3-(3,4-dimethoxyphenyl)propyl]phenoxy]ethylamine(215168-73-3)

Safety Data

• Hazardous Substances Data: 215168-73-3(Hazardous Substances Data)

Upstream product

• 215168-72-2 tert-butyl 2-{3-[3-(3,4-dimethoxyphenyl)propane]phenoxy}ethylcarbamate 
• 121-71-1 3-Hydroxyacetophenone 
• 39684-80-5 2-(tert-butoxycarbonylamino)ethyl bromide 
• 120-14-9 3,4-dimethoxy-benzaldehyde 
• 178445-83-5 3-(3,4-dimethoxyphenyl)-1-(3-hydroxyphenyl)-1-propanone 
• 178445-80-2 (E)-1-(3,4-dimethoxyphenyl)-3-(3-hydroxyphenyl)prop-2-en-1-one 

Downstream Products

• 215168-84-6 (1R)-1-[3-[2-[N-(tert-butoxycarbonyl)ethanamine]phenoxy-3-(3,4-dimethoxyphenyl)-1-propanyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-piperidinecarboxylate 
• 2127390-15-0 (R)-1-(3-(2-aminoethoxy)phenyl)-3-(3,4-dimethoxyphenyl)propyl (S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate 
• 1356846-23-5 C₅₈H₇₂N₄O₁₄S 
• 1356846-35-9 C₃₉H₄₇ClN₂O₁₀S 

Relevant articles and documents

Synthesis of Shld Derivatives, Their Binding to the Destabilizing Domain, and Influence on Protein Accumulation in Transgenic Plants

A series of 35 analogues of Shld with modifications in the A-residue and the C-residues were prepared and investigated for binding to FKBP and GFP accumulation in transgenic plants. The modifications investigated explored variations that were supposedly i

PROTEASE INHIBITORS

Compounds useful as protease inhibitors are provided, as are methods of use and preparation of such compounds and compositions containing such compounds. In one embodiment, the compounds are useful for inhibiting HIV protease enzymes, and are therefore useful in slowing the proliferation of HIV.